LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Drug Safety Update › 16 Jun 2026
Drug Safety Update

ACE

Published on 16 Jun 2026 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Healthcare professionals should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, as treatment strategies differ significa…
Drug Safety Update on GOV.UK ↗ All events: ACE

What this means

Drug Safety Update is the MHRA bulletin for healthcare professionals: new safety information, restrictions of use and recommendations for monitoring.

Summary

Healthcare professionals should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, as treatment strategies differ significantly and bradykinin-mediated angioedema does not respond to standard treatment.

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.